EPRATUZUMAB

Epratuzumab Side Effects Epratuzumab Phase III Epratuzumab Clinical Trials Embody Trial Immunomedics Veltuzumab Cd22 anti|CD22 Monoclonal Antibodies




Cloud:

| Epratuzumab Side Effects | Epratuzumab Phase III | Epratuzumab Clinical Trials | Embody Trial | Immunomedics | Veltuzumab | Cd22 | anti-CD22 Monoclonal Antibodies |

| Epratuzumab | Germinal_center_B-cell_like_diffuse_large_B-cell_lymphoma | List_of_drugs:_Em-Ep | Index_of_oncology_articles | List_of_therapeutic_monoclonal_antibodies |



[ Link Deletion Request ]

epratuzumab lupus immunomedics epratuzumab immunomedics epratuzumab agenda 2014 epratuzumab side effects epratuzumab phase iii epratuzumab ucb epratuzumab blog



Epratuzumab


Epratuzumab ?
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target CD22
Clinical data
Legal status  ?
Identifiers
CAS number 205923-57-5 N
ATC code None
UNII 3062P60MH9 YesY
KEGG D04036 YesY
Chemical data
Formula  ?
 N (what is this?)  (verify)

Epratuzumab is a humanized monoclonal antibody. Potential uses may be found in oncology and in treatment of inflammatory autoimmune disorders, such as lupus (SLE).[1][2] The manufacturers in August 2009 announced success in early trials against SLE.[3]


Epratuzumab Mechanism


Epratuzumab binds to the glycoprotein CD22 of mature and malignant B-cells.


Epratuzumab See also



Epratuzumab External links





Epratuzumab Side Effects Epratuzumab Phase III Epratuzumab Clinical Trials Embody Trial Immunomedics Veltuzumab Cd22 anti|CD22 Monoclonal Antibodies

| Epratuzumab Side Effects | Epratuzumab Phase III | Epratuzumab Clinical Trials | Embody Trial | Immunomedics | Veltuzumab | Cd22 | anti-CD22 Monoclonal Antibodies | Epratuzumab | Germinal_center_B-cell_like_diffuse_large_B-cell_lymphoma | List_of_drugs:_Em-Ep | Index_of_oncology_articles | List_of_therapeutic_monoclonal_antibodies

Copyright:
Dieser Artikel basiert auf dem Artikel http://en.wikipedia.org/wiki/Epratuzumab aus der freien Enzyklopaedie http://en.wikipedia.org bzw. http://www.wikipedia.org und steht unter der Doppellizenz GNU-Lizenz fuer freie Dokumentation und Creative Commons CC-BY-SA 3.0 Unported. In der Wikipedia ist eine Liste der Autoren unter http://en.wikipedia.org/w/index.php?title=Epratuzumab&action=history verfuegbar. Alle Angaben ohne Gewähr.

Dieser Artikel enthält u.U. Inhalte aus dmoz.org : Help build the largest human-edited directory on the web. Suggest a Site - Open Directory Project - Become an Editor






Search: deutsch english español français русский

| deutsch | english | español | français | русский |




[ Privacy Policy ] [ Link Deletion Request ] [ Imprint ]